Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allarity Therapeutics (ALLR) Deferred Taxes (2024)

Allarity Therapeutics' Deferred Taxes history spans 1 years, with the latest figure at -$432000.0 for Q3 2024.

  • For Q3 2024, Deferred Taxes changed N/A year-over-year to -$432000.0; the TTM value through Jun 2025 reached -$432000.0, changed N/A, while the annual FY2024 figure was -$446000.0, 559.79% down from the prior year.
  • Deferred Taxes reached -$432000.0 in Q3 2024 per ALLR's latest filing, down from -$14000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of -$14000.0 in Q1 2024 to a low of -$432000.0 in Q3 2024.